Crossmark

Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults

Crossref DOI link: https://doi.org/10.1016/j.eimc.2015.01.018

Published Print: 2016-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gatell Artigas, Josep María

Arribas López, José Ramón

Lázaro y de Mercado, Pablo

Blasco Bravo, Antonio Javier
Funding

Funding for this research was provided by:

Fundación Máximo Soriano Jiménez

Red Española de Investigación en SIDA
License Information

Text and Data Mining valid from 2016-08-01
More Information

This article is maintained by: Elsevier

Article Title: Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults

Journal Title: Enfermedades Infecciosas y Microbiología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimc.2015.01.018

Content Type: article

Copyright: © 2015 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Document is current

Any future updates will be listed below